Skip to main content
. 2020 Mar 24;10(3):177–186. doi: 10.34172/bi.2020.22

Fig. 2.

Fig. 2

The impact of SM and LAC chronic administration on muscle strength. (A) Evaluation of muscle strength by measurement of latency to fall in 3 trials before treatment administration. (B) Evaluation of muscle strength in 3 trials after treatment administration for eight weeks. (C) Comparing Mean of 3 trials of latency to fall before and after treatment administration. Abbreviations: TAA, Thioacetamide; LAC, Lactulose; SM, Silymarin; SM+LAC, Silymarin + Lactulose. *Compared with the control group P <0.05.